• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protein FAM46C (FAM46C)

ACP09097

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09097 Target NameFAM46C
Target SynonymsFA46C_HUMAN; Fam46c; Family with sequence similarity 46 member C; Protein FAM46CFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-391
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5VWP2
Background Information
  • Uniprot Id

    Q5VWP2

  • Target Species

    Human

  • Target Name

    TENT5C

  • Target Full Name

    Terminal nucleotidyltransferase 5C

  • Target Function

    Nucleotidyltransferase that act as a non-canonical poly(A) RNA polymerase which enhances mRNA stability and gene expression. Mainly targets mRNAs encoding endoplasmic reticulum-targeted protein and may be involved in induction of cell death.; (Microbial infection) Seems to enhance replication of some viruses, including yellow fever virus, in response to type I interferon.

  • Target Subcellular Location

    Nucleus. Cytoplasm.

  • Target Protein Families

    FAM46 family

  • Target Research Area

    Cell Biology

  • Target Synonyms

    FA46C_HUMAN; Fam46c; Family with sequence similarity 46 member C; Protein FAM46C

  • Target Background

    Enables RNA adenylyltransferase activity. Involved in mRNA stabilization. Located in cytoplasm and nucleoplasm.

Inquire Recombinant Human Protein FAM46C (FAM46C) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification